The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
585 Stewart Avenue, Suite 18
Garden City, NY 11530
The Children's Leukemia Research Association (CLRA), also known as the National Leukemia Research Association, was founded in 1965 as a non-profit organization to raise funds for research into the causes of, and possible cures for, leukemia, and to provide assistance to families in need as a result of the expenses incurred during leukemia treatment. Leukemia is any of several types of cancer in which there is usually an abnormal accumulation of white blood cells within the bone marrow, often resulting in decreased production of red blood cells, platelets, and normal white blood cells. Organs such as the liver, lymph nodes, and brain may fail to function properly as they are infiltrated by leukemia cells. The two key functions of the CLRA are its Research Grant Program and its Patient Aid Program.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.